Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$311,818
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#593
of 1,033 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prairie Wealth Advisors, Inc. holds $8,080,397 across 9 Drug Manufacturers - General names. GSK ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
0 | $2,745,919 | |
| 2 | AMGN |
Amgen Inc
|
0 | $1,629,721 | |
| 3 | JNJ |
Johnson & Johnson
|
0 | $1,328,009 | |
| 4 | ABBV |
AbbVie Inc.
|
0 | $909,175 | |
| 5 | NVS |
Novartis AG
|
0 | $399,636 | |
| 6 | GSK |
GSK plc
This page
|
0 | $311,818 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
0 | $272,389 | |
| 8 | MRK |
Merck & Co., Inc.
|
0 | $269,979 |
All Filings in GSK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $311,818 | 0 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||